Acadia Pharmaceuticals reported $-27183000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
ALKERMES ALKS:US USD -63974000 33.84M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Aptinyx Inc APTX:US USD -15303000 2.36M
Biogen BIIB:US USD 1.13B 76.7M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Bristol Myers Squibb BMY:US USD 1.61B 185M
Cara Therapeutics CARA:US USD -23180000 18.97M
Corcept Therapeutics CORT:US USD 34.61M 7.2M
Cytokinetics CYTK:US USD -142310000 122.49M
Eisai 4523:JP JPY 3.57B 23.33B
Eli Lilly And LLY:US USD 1.45B 499.2M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Intra Cellular Therapies ITCI:US USD -53508000 33.1M
Johnson & Johnson JNJ:US USD 4.46B 356M
Marinus Pharmaceuticals MRNS:US USD 73.29M 112.72M
Moderna Inc MRNA:US USD 1.04B 1.15B
Neurocrine Biosciences NBIX:US USD 68.5M 85.4M
Pfizer PFE:US USD 8.61B 1.3B
Ptc Therapeutics PTCT:US USD -109315000 42.77M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Seattle Genetics SGEN:US USD -190816000 55.99M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M
YTE INCY:US USD 112.78M 48.66M